Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 9, 2009
Smoking Kills Millions Worldwide Every Year
December 9, 2009Tobacco use kills at least 5 million people every year, a figure that could rise if countries don't take stronger measures to combat smoking, the World Health Organization said Wednesday.
In a new report on tobacco use and control, the U.N. agency said nearly 95 percent of the global population is unprotected by laws banning smoking. WHO said secondhand smoking kills about 600,000 people every year.
The report describes countries' various strategies to curb smoking, including protecting people from smoke, enforcing bans on tobacco advertising, and raising taxes on tobacco products. Those were included in a package of six strategies WHO unveiled last year, but less than 10 percent of the world's population is covered by any single measure.
"People need more than to be told that tobacco is bad for human health," said Douglas Bettcher, director of WHO's Tobacco-Free Initiative. "They need their governments to implement the WHO Framework Convention."
Most of WHO's anti-tobacco efforts are centered on the Framework Convention on Tobacco Control, an international treaty ratified by nearly 170 countries in 2003. The convention theoretically obliges countries to take action to reduce tobacco use, though it is unclear if they can be punished for not taking adequate measures, since they can simply withdraw from the treaty.
Other experts questioned how effective WHO's strategies were.
"It's like the well-intentioned blind leading the blind," said Patrick Basham, director of the Democracy Institute, a London and Washington-based think tank. He said WHO's policies were based more on hope than evidence.
Basham said measures like increasing taxes on tobacco products and banning advertising don't address the root causes of why people smoke. Smoking levels naturally drop off â€" as they have in Western countries â€" when populations become richer and better-educated.
Tobacco use is the leading preventable cause of death and WHO estimates that, unless countries take drastic action, tobacco could kill about 8 million people every year by 2030, mostly in developing countries.
Basham said officials should focus on anti-poverty measures to stem the smoking problem, though that is beyond WHO's mandate as a health agency.
"The cynical view is that the anti-tobacco lobby has itself now become an industry and we will never be able to do enough to stop smoking," Basham said. "Tobacco use will change, but it has very little to do with the kinds of things WHO is promoting."
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16] 17
October 17, 2011 | Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide RiskWASHINGTON, June 12, 2008 Senator Chuck Grassley has asked the Food and Drug Administration to carefully scrutinize information it received from drug maker GlaxoSmithKline about the anxiety disorder drug Paxil, based on the contents of a newly available report about the drug's risk for suicide among adults. Grassley also asked the FDA to review findings released earlier this year by the British drug-safety ...
September 21, 2009 | Topical cream studied for erectile dysfunctionScientists from Albert Einstein College of Medicine of Yeshiva University are working on a cream to rub on and treat erectile dysfunction (ED). The cream could prove to be safer than oral medications used to deliver nitric oxide to the cells that improves blood flow to treat impotency. Using encapsulated nanoparticles, the scientists have found a way to deliver nitric oxide and ...
May 21, 2012 | Onyx Rises on Analyst View of Blood Cancer DrugNEW YORK -- Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company’s blood cancer drug candidate will reach $1 billion in annual sales by 2016. THE SPARK: Analyst Geoffrey Porges ...
Related articles:
Chronic prostatitis/chronic pelvic pain syndrome - diagnosis
There are no definitive diagnostic tests for CP/CPPS. This is a poorly understood disorder, even though it accounts for 90%-95% of prostatitis diagnoses. It is found in men of any age, with the peak onset in the early 30s. CP/CPPS may be inflammatory (Category IIIa) or non-inflammatory (Category IIIb), based on levels of pus cells in ...Section: Prostatitis
Chronic bacterial prostatitis - signs and symptoms
Chronic bacterial prostatitis is a relatively rare condition - occurs in less than 5% of patients with prostate-related non-BPH lower urinary tract symptoms (LUTS) - that usually presents with an intermittent UTI-type picture and that is defined as recurrent urinary tract infections in men originating from a chronic infection in the ...Section: Prostatitis
Chronic prostatitis/chronic pelvic pain syndrome - prevalence
The annual prevalence in the general population of chronic pelvic pain syndrome is 0.5%. 38% of primary care providers, when presented with a vignette of a man with CPPS, indicate that they have never seen such a patient. However, the overall prevalence of symptoms suggestive of CP/CPPS is 6.3%. The role of the prostate was questoned in the etiology of CP/CPPS when both men and women in the general population were tested using the (1) National Institutes of Health Chronic Prostatitis ...Section: Prostatitis